Hypothalmapath

Wirkstoff: GELSEMIUM SEMPERVIRENS ROOT, GINKGO, LICORICE, CENTELLA ASIATICA WHOLE, BOS TAURUS HYPOTHALAMUS, PETROSELINUM CRISPUM WHOLE, SUS SCROFA PITUITARY GLAND, POSTERIOR, PYRIDOXINE HYDROCHLORIDE, SENNA LEAF, SILICON DIOXIDE

Flüssigkeit [Übersetzung der Form; Original: LIQUID (openFDA)] · GELSEMIUM SEMPERVIRENS ROOT 12 [hp_X]/59.1mL, GINKGO 6 [hp_X]/59.1mL, LICORICE 4 [hp_X]/59.1mL, CENTELLA ASIATICA WHOLE 4 [hp_X]/59.1mL, BOS TAURUS HYPOTHALAMUS 12 [hp_X]/59.1mL, PETROSELINUM CRISPUM WHOLE 4 [hp_X]/59.1mL, SUS SCROFA PITUITARY GLAND, POSTERIOR 12 [hp_X]/59.1mL, PYRIDOXINE HYDROCHLORIDE 12 [hp_X]/59.1mL, SENNA LEAF 8 [hp_X]/59.1mL, SILICON DIOXIDE 12 [hp_X]/59.1mL

Vereinigte Staaten·Aktiv

Zulassungsinhaber: Energetix Corporation

Geprüft 2026-10-09 · openFDA NDC